FBLG
FibroBiologics, Inc. Common Stock
NASDAQ: FBLG · HEALTHCARE · BIOTECHNOLOGY
$1.32
+0.76% today
Updated 2026-04-30
Market cap
$6.45M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.40
Dividend yield
—
52W range
$1 – $23
Volume
1.0M
FibroBiologics, Inc. Common Stock (FBLG) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-419.40%
ROA
-79.80%
Debt/equity
56.90x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | — | $-1.17M | — | — | — |
| 2022 | $0.00 | $-1.58M | — | — | — |
| 2023 | $0.00 | $-5.12M | — | — | — |
| 2024 | $0.00 | $-16.48M | — | — | — |
| 2025 | $0.00 | $-11.16M | — | — | — |